Cardiosense

Cardiosense is a healthcare technology company specializing in the development of a digital biomarker platform for early detection of heart disease. The platform leverages novel multi-sensor devices and proprietary algorithms to analyze raw biosignals and identify pre-symptomatic markers of cardiac disease. Their flagship product, the CardioTag Sensor, is a medical-grade wearable device designed for wireless patient monitoring, both in hospitals and at home. The data collected by the sensor is then processed through the Wavesense platform, which aggregates, transmits, and analyzes physiological data.

The company’s focus on advanced signal processing and AI-driven clinical analysis has resulted in a series of successful publications in leading medical journals. Cardiosense has received significant funding and recognition for its innovative approach, including a Breakthrough Device designation from the FDA and numerous awards for its technology. They are actively involved in clinical trials and collaborations with industry partners, demonstrating their commitment to advancing early detection and personalized therapy in the fight against heart disease.

Cardiosense is a company dedicated to advancing cardiac care through digital biomarkers. Their mission is to leverage novel, multi-sensor devices and proprietary algorithms to detect early signs of heart disease, enabling personalized treatment and improved patient outcomes. Their work, rooted in over a decade of research, focuses on developing an end-to-end patient monitoring and sensor analytics ecosystem, including their CardioTag wearable sensor, the Wavesense platform for data aggregation and analysis, and Clinical AI that utilizes deep learning to identify pre-symptomatic markers of cardiac disease.

Cardiosense promotes a culture of innovation and research, focused on developing cutting-edge technology in the field of cardiac care. Their commitment to pushing boundaries is evident in their ongoing research efforts, reflected in numerous publications in prestigious medical journals. The company values collaboration and partnership, working with leading healthcare institutions and industry experts to advance their mission. This collaborative spirit is also reflected in their commitment to sharing their knowledge through podcasts and public discussions on topics related to academia and entrepreneurship.